AVO-101

N/A

Report date: 2025/01/26 17:06:34
NME

Base Information

Drug NameAVO-101
Drug Alias Namebazlitoran (Avogadro)AVO-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 9 antagonists
TargetsToll like receptor 9
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvogadro Development Corp
China Registration ClassN/A

Develop Information

Active CompaniesAvogadro Development Corp
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A